Drug Oncology

Lorbrena

Payments companies reported to CMS as associated with Lorbrena. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.6Massociated payments (2023-2025)
6,346clinicians with associated payments
5companies reporting

By year

2023 $372K
2024 $533K
2025 $665K

Payments reported as associated with Lorbrena, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Hematology & Oncology $744K
Medical Oncology $353K
Family $100K
Internal Medicine $79K
Diagnostic Radiology $58K
Nurse Practitioner $46K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Lorbrena

These are the largest totals companies reported as associated with Lorbrena. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Martin Dietrich Rockledge, FL Hematology & Oncology $159,258.06
Todd Bauer Nashville, TN Hematology & Oncology $75,667.41
Ryan Nguyen Chicago, IL Hematology & Oncology $62,298.73
Misako Nagasaka Orange, CA Hematology & Oncology $57,367.87
Mary Grizzard Franklin, TN Family $54,559.03
Justin Gainor Boston, MA Medical Oncology $46,679.51
Edgardo Santos Fort Lauderdale, FL Hematology & Oncology $33,362.13
Ibiayi Dagogo-Jack Boston, MA Internal Medicine $26,717.96
Christine Lovly Duarte, CA Medical Oncology $26,351.21
Sarah Sagorsky Baltimore, MD Medical $24,922.93

Prescribed Lorbrena?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.